Related Experiment Videos
Complement fixation in acute serum sickness: assembly of glomerular-bound C3-convertase
Clinical and Experimental Immunology
|September 1, 1979
Summary
Glomerular immune deposits in acute serum sickness primarily activate the alternative complement pathway, a process that diminishes as nephritis progresses. This study investigated complement fixation in rabbit models to understand the underlying mechanisms.
Area of Science:
- Immunology
- Nephrology
- Complement System Biology
Background:
- Glomerular immune deposits are implicated in nephritis pathogenesis.
- The role of complement activation pathways in acute serum sickness (ASS) requires detailed investigation.
Purpose of the Study:
- To elucidate the complement (C) fixing properties of glomerular immune deposits in acute serum sickness (ASS) in vitro.
- To determine the predominant complement pathway involved in glomerular C deposition during ASS.
Main Methods:
- In vitro study using two groups of rabbits with ASS: decomplemented (cobra venom factor-treated) and non-decomplemented.
- Perfusion of rabbit kidneys with complement-deficient or pathway-inhibited sera to assess C3 fixation.
- Incubation of kidney sections with purified complement factors and human/guinea-pig C3 to evaluate deposition.
Main Results:
- C3 fixation occurred in both classical and alternative pathway assays in Group I (decomplemented) rabbits, but not with EDTA-treated serum.
- In Group II (non-decomplemented) rabbits, C3 fixation to deposits was observed with factors B and D, indicating alternative pathway involvement.
- Pre-incubation with C3b-inactivator reduced C3 fixation, while depletion of factor D from classical pathway components abolished it.
Conclusions:
- Glomerular complement deposition in acute serum sickness is predominantly driven by alternative pathway activation (C3b-feedback).
- This alternative pathway-dependent complement fixation is progressively lost during the nephritis evolution in ASS.
- Findings highlight the dynamic role of complement pathways in the immunopathology of acute serum sickness.